Santen Announces Approval of TAPROS
2015-8-25 · Santen Announces Approval of TAPROS. for the Treatment of Open-Angle Glaucoma and Ocular Hypertension in China. August 25, 2015, Osaka, Japan– Santen Pharmaceutical (hereinafter, Santen)Co., Ltd. announced today that it received an import drug license of TAPROS Ophthalmic Solution 0.0015%
Get Price